Skip to content
FR · Français
Get started
Registry

AI co-scientist: hypotheses validated in vitro on acute myeloid leukaemia (AML) and liver fibrosis

Status

Peer reviewed

Recorded on · nature.com

  1. Announced
  2. Recordednot evaluated
  3. Revisedpeer reviewed
What this status means

Source reading : Source read word for word (level 3 of 3)

Published in a journal or reviewed by named experts.

Full history

The gist

Google Research and DeepMind, with Stanford, present an AI co-scientist whose hypotheses were validated in vitro, in an article published by Nature on 19 May 2026.

FollowReport

Cite this entry

The status has changed 1 times since Oct 11, 2026: a citation always points to a dated snapshot.

Cite snapshot 2, Oct 18, 2026

APA citation with the dated link

DiscoverIA. (2026, October 18,). AI co-scientist: hypotheses validated in vitro on acute myeloid leukaemia (AML) and liver fibrosis [Status : Peer reviewed, snapshot 2]. DiscoverIA registry. https://discoveria.ai/en/fiche/google-co-scientist-2025-02/#releve-2

BibTeX @misc, key discoveria-google-co-scientist-2025-02-r2

@misc{discoveria-google-co-scientist-2025-02-r2,
  author       = {{DiscoverIA}},
  title        = {AI co-scientist: hypotheses validated in vitro on acute myeloid leukaemia (AML) and liver fibrosis},
  howpublished = {DiscoverIA registry, entry google-co-scientist-2025-02},
  note         = {Status « Peer reviewed », snapshot 2, recorded on October 18, 2026. new result},
  year         = {2026},
  url          = {https://discoveria.ai/en/fiche/google-co-scientist-2025-02/#releve-2},
  urldate      = {2026-10-18}
}

Dated link opens this snapshot in the history

https://discoveria.ai/en/fiche/google-co-scientist-2025-02/#releve-2

Text written by an AI (DiscoverIA pipeline), on Reviewed by: Antoine Olivier, Oct 18, 2026Report an error

What has not been reviewed?

The status and its sources come from the registry; the explanatory text has been reviewed by a human.

The status and its sources come from the registry; the explanatory text has been reviewed by a human.

Key facts

Claimed by
Google Research / DeepMind avec Stanford
announced on Feb 2025
Nature
new result
Field
Biology and medicine (biology / biomedicine)
Checked by
Nature peer review: Olivier Elemento and Linfeng Zhang (named reviewers) and one anonymous reviewer; experiments reported by the claimant and their collaborators
Sources (domains)
2 : 1 read word for word, 1 links only
This entry
Reviewed by Antoine Olivier, Oct 18, 2026

To understand

Analogy

It is a bit like a colleague who reads the whole literature and hands the team a ranked list of ideas to test, leaving the humans to check them.

What it changes

A peer-reviewed article describes an AI system that proposes testable biomedical hypotheses: existing drugs to repurpose against acute myeloid leukaemia (AML, a blood cancer) and leads against liver fibrosis. The validations cited remain in vitro (in the lab, outside a living organism), far from a treatment.

What remains unclear

The experiments are reported by the claimant and its collaborators; no independent reproduction is recorded. For the cf-PICI episode, published in Cell, the work is the human team's: the AI gave back the hypothesis ranked first (secondary source).

For experts

2 sources.

For experts

Proofs
preprint arXiv, article Nature du 2026-05-19 (DOI 10.1038/s41586-026-10644-y, relu par les pairs), expériences in vitro (revendicateur)

Sources(domains)

  • primairenature.compage read word for word · consulted on Oct 18, 2026 · acute myeloid leukaemia (AML)
  • articlearxiv.orglink only, reading not recorded

Method

The Nature article (DOI 10.1038/s41586-026-10644-y), the published version of arXiv preprint 2502.18864, reports in vitro tests of drug-repurposing candidates for AML and of leads for liver fibrosis. Nature thanks two named reviewers, Olivier Elemento and Linfeng Zhang, and one anonymous reviewer. Status “peer reviewed” recorded on 18 October 2026 from nature.com (page read, quotation checked word for word). History: 2 dated observations, oldest first.

Limits

The status may change if a new source is published; the dated history stays visible.

To understand

It is a bit like a colleague who reads the whole literature and hands the team a ranked list of ideas to test, leaving the humans to check them.

Status history

The numbers link the band (order of observations) and the thread (most recent first). Band segments have equal widths, not a time scale.

  1. 02

    Not evaluatedbecomesPeer reviewedCurrent status

    published version of the arXiv preprint 2502.18864: Nature, published 2026-05-19, DOI 10.1038/s41586-026-10644-y; named reviewers Olivier Elemento and Linfeng Zhang, plus one…

    Read the full reason

    published version of the arXiv preprint 2502.18864: Nature, published 2026-05-19, DOI 10.1038/s41586-026-10644-y; named reviewers Olivier Elemento and Linfeng Zhang, plus one anonymous reviewer

    Source: nature.comread word for word

  2. 01

    First observation:Not evaluatednot confirmed

    Source: arxiv.orgsearch-engine snippet only

An observation is added; none is ever erased.

Report an error or suggest a source

How DiscoverIA uses your address and how to exercise your rights: privacy policy.

Bot check not configured.